Capricor Therapeutics, Inc.Share Price
|
|
Share Price & Volume
| Previous Close | $33.42 | |
| Open | -1.26% | $33.00 |
| Day Low | -12.00% | $29.41 |
| Day High | -1.26% | $33.00 |
| 52-Week Low | -87.13% | $4.30 |
| 52-Week High | +20.80% | $40.37 |
| Day Volume | 2,597,535 | |
| Average Volume | 1,313,385 | |
| EPS (TTM) | -$1.75 | |
| P/E (TTM) | -17.43x | |
| FWD P/E (NTM) | 78.74x | |
| Next Earnings Date | May 13, 2026 |
| Market Cap | 1,394,370,117 | |
| Shares Outstanding (Millions) | 45,717,053 | |
| Dividend | - | |
| Beta | 0.48 | |
| ROE | -1.08% | |
| ROA | -0.49% |
Analyst Ratings and Price Targets
Current:
$30.50
Average:
$58.20
(+90.82%)
Low:
$50.00
(+63.93%)
High:
$63.00
(+106.56%)
| B. Riley Securities | Maintains | Buy | $63.00 | +106.56% | Mar 12, 2026 |
| Piper Sandler | Reiterates | Overweight | $58.00 | +90.16% | Mar 12, 2026 |
| HC Wainwright & Co. | Reiterates | Buy | $60.00 | +96.72% | Mar 12, 2026 |
| HC Wainwright & Co. | Reiterates | Buy | $60.00 | +96.72% | Mar 9, 2026 |
| B. Riley Securities | Reiterates | Buy | $50.00 | +63.93% | Dec 15, 2025 |
Headquarters
San Diego, CA, USA
Sector
Industry
# of Employees
160